RU2008143055A - Ингибиторы ренина, предназначенные для гипертензии - Google Patents

Ингибиторы ренина, предназначенные для гипертензии Download PDF

Info

Publication number
RU2008143055A
RU2008143055A RU2008143055/14A RU2008143055A RU2008143055A RU 2008143055 A RU2008143055 A RU 2008143055A RU 2008143055/14 A RU2008143055/14 A RU 2008143055/14A RU 2008143055 A RU2008143055 A RU 2008143055A RU 2008143055 A RU2008143055 A RU 2008143055A
Authority
RU
Russia
Prior art keywords
renin inhibitor
administration
hypertension
antihypertensive effect
cancellation
Prior art date
Application number
RU2008143055/14A
Other languages
English (en)
Russian (ru)
Inventor
Эндрью САТЛИН (US)
Эндрью САТЛИН
Original Assignee
Новартис АГ (CH)
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2008143055(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис АГ (CH), Новартис Аг filed Critical Новартис АГ (CH)
Publication of RU2008143055A publication Critical patent/RU2008143055A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2008143055/14A 2006-04-03 2007-03-30 Ингибиторы ренина, предназначенные для гипертензии RU2008143055A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
US60/788,842 2006-04-03

Publications (1)

Publication Number Publication Date
RU2008143055A true RU2008143055A (ru) 2010-05-10

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008143055/14A RU2008143055A (ru) 2006-04-03 2007-03-30 Ингибиторы ренина, предназначенные для гипертензии

Country Status (20)

Country Link
US (1) US20090062395A1 (enExample)
EP (1) EP2004167A1 (enExample)
JP (1) JP2009532494A (enExample)
KR (1) KR20080108515A (enExample)
CN (1) CN101415413A (enExample)
AU (1) AU2007234917B2 (enExample)
BR (1) BRPI0710095A2 (enExample)
CA (1) CA2645260A1 (enExample)
CL (1) CL2007000912A1 (enExample)
IL (1) IL193905A0 (enExample)
MA (1) MA30387B1 (enExample)
MX (1) MX2008012729A (enExample)
NO (1) NO20084625L (enExample)
NZ (1) NZ571251A (enExample)
RU (1) RU2008143055A (enExample)
SG (1) SG170830A1 (enExample)
TN (1) TNSN08383A1 (enExample)
TW (1) TW200806283A (enExample)
WO (1) WO2007118023A1 (enExample)
ZA (1) ZA200807615B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
EP2768971A1 (en) 2011-10-20 2014-08-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the detection and the treatment of cardiac remodeling
AU2020259450A1 (en) * 2019-04-18 2021-11-18 EyePoint Pharmaceuticals, Inc. Methods of treating hypertension with activators of Tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
JP2005537822A (ja) * 2002-06-28 2005-12-15 ノバルティス アクチエンゲゼルシャフト 有機化合物の使用
US20040266743A1 (en) * 2003-05-09 2004-12-30 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
WO2005037317A2 (en) * 2003-10-17 2005-04-28 Cornell Research Foundation, Inc. Mast cell-derived renin
MY148773A (en) * 2004-03-17 2013-05-31 Novartis Ag Galenic formulations of organic compounds
ES2310293T3 (es) * 2004-09-27 2009-01-01 Pantarhei Bioscience B.V. Tratamiento o prevencion de sangrados no programados en mujeres bajo medicacion que contiene progestogeno.

Also Published As

Publication number Publication date
US20090062395A1 (en) 2009-03-05
MX2008012729A (es) 2008-10-14
MA30387B1 (fr) 2009-05-04
AU2007234917A1 (en) 2007-10-18
NO20084625L (no) 2008-11-03
IL193905A0 (en) 2009-08-03
EP2004167A1 (en) 2008-12-24
CL2007000912A1 (es) 2008-03-14
TW200806283A (en) 2008-02-01
JP2009532494A (ja) 2009-09-10
KR20080108515A (ko) 2008-12-15
SG170830A1 (en) 2011-05-30
BRPI0710095A2 (pt) 2011-08-02
WO2007118023A1 (en) 2007-10-18
AU2007234917B2 (en) 2011-05-12
CA2645260A1 (en) 2007-10-18
NZ571251A (en) 2011-12-22
ZA200807615B (en) 2009-10-28
TNSN08383A1 (en) 2009-12-29
CN101415413A (zh) 2009-04-22

Similar Documents

Publication Publication Date Title
US10028926B2 (en) Methods of reducing risk of cardiovascular disease
RU2012118974A (ru) Комбинации ингибитора pi3k и ингибитора мек
RU2015110240A (ru) Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия
KR20100057704A (ko) 발사르탄 및 ｎｅｐ 저해제를 포함하는 제약학적 조성물
MX2025001619A (es) Inhibidor de pde4b y uso del mismo
RU2013155509A (ru) Применение ингибирования катепсина к для лечения и/или профилактики легочной гипертензии и/или сердечной недостаточности
FI3972603T3 (fi) Menetelmiä sjögrenin oireyhtymän hoitamiseksi käyttäen brutonin tyrosiinikinaasin estäjää
RU2008143055A (ru) Ингибиторы ренина, предназначенные для гипертензии
CA2291160C (en) Combination therapy for modulating the human sexual response
EP3132803B1 (en) Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
PT1487424E (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-il-amino)fenil]-benzamida para o tratamento doenças mediadas por ang ii
EP3820470B1 (en) Alkoxy pyrazoles as soluble guanylate cyclase activators for use in treating portal hypertension
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JP2019531286A5 (enExample)
JPS59206309A (ja) 急発作障害の処置及びそれに有用な製薬組成物
NO20044568L (no) Fremgangsmate for inhibering av atrofi eller for behandling eller forhindring av atrofi-relaterte symptomer i kvinner
FI3648761T3 (fi) Telmisartaani kissan hypertension ehkäisemiseksi tai hoitamiseksi
US20080051438A1 (en) Preventive/Therapeutic Compositions Useful for Treating Cardiovascular Diseases
JP2009532494A5 (enExample)
MX2012015040A (es) Agente terapeutico de liberacion sostenida para la hipertension y la disfuncion renal.
US20060128719A1 (en) Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
TWI354553B (en) Drug for glomerular diseases
KR20090117703A (ko) 알리스키렌 및 아보센탄을 이용한 의약 조성물
RU2009149637A (ru) Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни
US20050267124A1 (en) Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors